MktsMarkets

Dare Bioscience, Inc.
NASDAQ: DAREKey statistics
DARE News
Stories mentioning DARE from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 152.00 | 2.00 | 25.00 | (63.00) | 42.00 | 22.00 | ||
| Cost of Goods Sold | 242.00 | 0.00 | ||||||
| Gross Profit | (90.00) | 0.00 | 25.00 | |||||
| Operating Expenses | ||||||||
| Research & Development | 660.00 | 622.00 | 1,175 | 1,429 | 2,297 | 3,335 | 2,682 | 4,934 |
| Sales General & Admin | 2,249 | 2,309 | ||||||
| Total Operating Expenses | 2,909 | 2,199 | 3,674 | 3,807 | 4,607 | 5,324 | 4,723 | 7,382 |
| Operating Income (Loss) | (2,999) | (1,471) | (3,672) | (3,828) | (4,581) | (5,389) | (4,681) | (7,359) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (1.00) | (276.00) | 109.00 | (189.00) | 203.00 | 1,844 | (21.00) | (109.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (3,000) | (1,442) | (3,563) | (4,016) | (4,378) | (5,507) | (4,703) | 12,911 |
| Earnings Per Share (Basic) | (0.21) | (0.13) | (0.28) | (0.45) | (0.50) | (0.65) | (0.55) | 1.53 |
| Earnings Per Share (Diluted) | (0.21) | (0.13) | (0.28) | (0.45) | (0.50) | (0.65) | (0.55) | 1.52 |
| Weighted Average Shares Outstanding (Basic) | 14,523 | 11,179 | 12,755 | 8,871 | 8,759 | 8,497 | 8,534 | 8,411 |
| Weighted Average Shares Outstanding (Diluted) | 14,523 | 11,179 | 12,755 | 8,871 | 8,759 | 8,497 | 8,534 | 8,476 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About DARE
Dare Bioscience, Inc. (NASDAQ: DARE) is a stock listed on the Nasdaq Stock Market under the ticker symbol DARE. It last traded at $0.6500 (Nov 12, 2026, 3:38 PM ET), down 6.9% on the day. That gives Dare Bioscience a market capitalisation of $13.0M.
Over the past 52 weeks DARE has traded between $0.6100 and $3.78.
Revenue for the quarter ended Mar 31, 2026 was $152.0K; a net loss of $3.0M. Revenue was up 508% from $25.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $152.0K | -$3.0M | -1973.7% |
| Dec 31, 2025 | — | -$1.4M | — |
| Sep 30, 2025 | $2.0K | -$3.6M | -178150.0% |
| Jun 30, 2025 | — | -$4.0M | — |
From Dare Bioscience’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…